Carmat SA
PAR:ALCAR

Watchlist Manager
Carmat SA Logo
Carmat SA
PAR:ALCAR
Watchlist
Price: 1.066 EUR -5.5% Market Closed
Market Cap: 45.2m EUR
Have any thoughts about
Carmat SA?
Write Note

Carmat SA
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Carmat SA
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
Carmat SA
PAR:ALCAR
Total Liabilities & Equity
€54.2m
CAGR 3-Years
-15%
CAGR 5-Years
16%
CAGR 10-Years
17%
Edap Tms SA
NASDAQ:EDAP
Total Liabilities & Equity
€91.5m
CAGR 3-Years
18%
CAGR 5-Years
13%
CAGR 10-Years
13%
Biomerieux SA
PAR:BIM
Total Liabilities & Equity
€5.3B
CAGR 3-Years
9%
CAGR 5-Years
8%
CAGR 10-Years
9%
Biosynex SA
PAR:ALBIO
Total Liabilities & Equity
€208.8m
CAGR 3-Years
-7%
CAGR 5-Years
39%
CAGR 10-Years
39%
Visiomed Group SA
PAR:ALVMG
Total Liabilities & Equity
€36.6m
CAGR 3-Years
84%
CAGR 5-Years
15%
CAGR 10-Years
11%
Amplitude Surgical SA
PAR:AMPLI
Total Liabilities & Equity
€279.3m
CAGR 3-Years
1%
CAGR 5-Years
0%
CAGR 10-Years
N/A
No Stocks Found

Carmat SA
Glance View

Market Cap
45.2m EUR
Industry
Health Care

Carmat SA engages in the developing of implantable orthotropic and biocompatible artificial heart. The company is headquartered in Velizy-Villacoublay, Ile-De-France and currently employs 160 full-time employees. The company went IPO on 2010-07-07. The firm is developing an orthotopic and biocompatible artificial heart which works like a natural heart and which is hydraulically activated. The firm formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels and Blood Institute, Laboratoire de Recherche Biochirurgicale and others. As of December 31, 2011, a company MATRA DEFENSE held a 30.57% stake in the Company’s shareholdings.

ALCAR Intrinsic Value
4.995 EUR
Undervaluation 79%
Intrinsic Value
Price

See Also

What is Carmat SA's Total Liabilities & Equity?
Total Liabilities & Equity
54.2m EUR

Based on the financial report for Jun 30, 2024, Carmat SA's Total Liabilities & Equity amounts to 54.2m EUR.

What is Carmat SA's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
17%

Over the last year, the Total Liabilities & Equity growth was -16%. The average annual Total Liabilities & Equity growth rates for Carmat SA have been -15% over the past three years , 16% over the past five years , and 17% over the past ten years .

Back to Top